NASDAQ
Cyclo Therapeutics, Inc. (CYTH) has a fcf yield of -62.35% as of Friday, May 29, 2026. This represents a 24.65% increase compared to its 12-month average of -82.74%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.